Skip to main content
Livermore
Livermore
ZHEN

Westpac Banking Corp

SEC CIK
0000719245
Latest filing
Aug 12, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Westpac Banking Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
2,632
Value
$792.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Westpac Banking Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,632$792.3K<0.1%+180+7.3%AddedHolders
Q1 20262,452$811.3K0.1%−2,859−53.8%ReducedHolders
Q4 20255,311$2.11M0.1%+3,956+292.0%AddedHolders
Q3 20251,355$617.9K<0.1%00.0%UnchangedHolders
Q2 20251,355$441.9K<0.1%−3,718−73.3%ReducedHolders
Q1 20255,073$1.37M0.1%−5,487−52.0%ReducedHolders
Q4 202410,560$2.48M0.2%+4,819+83.9%AddedHolders
Q3 20245,741$1.58M0.1%+4,274+291.3%AddedHolders
Q2 20241,467$356.5K<0.1%00.0%UnchangedHolders
Q1 20241,467$219.2K<0.1%−45−3.0%ReducedHolders
Q4 20231,512$289.4K<0.1%+566+59.8%AddedHolders
Q3 2023946$167.5K<0.1%00.0%UnchangedHolders
Q2 2023946$179.7K<0.1%−10,316−91.6%ReducedHolders
Q1 202311,262$2.26M<0.1%00.0%UnchangedHolders
Q4 202211,262$2.68M<0.1%+861+8.3%AddedHolders
Q3 202210,401$2.08M<0.1%+1,877+22.0%AddedHolders
Q2 20228,524$1.24M<0.1%00.0%UnchangedHolders
Q1 20228,524$1.39M<0.1%00.0%UnchangedHolders
Q4 20218,524$1.45M<0.1%−2,445−22.3%ReducedHolders
Q3 202110,969$2.07M<0.1%00.0%UnchangedHolders
Q2 202110,969$1.86M<0.1%00.0%UnchangedHolders
Q1 202110,969$1.55M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.